Clinical Professor of Surgery and University Head of the Division of Cardiac Surgery at the University of British Columbia
St. Paul's Hospital
Dr. Samuel V. Lichtenstein is Clinical Professor of Surgery and University Head of the Division of Cardiac Surgery at the University of British Columbia. Besides his medical degree, Dr. Lichtenstein holds a Ph.D. in biomedical engineering from the Johns Hopkins University School of Medicine. Publications include approximately 140 peer reviewed articles and invited reviews. Early in his career, he introduced the notion of performing open heart surgery at normothermia which challenged previously held concepts of hypothermia in open heart surgery. In 2005, Dr. Lichtenstein and his group were the first in the world to implant an aortic valve for aortic stenosis through the apex of the left ventricle in man. Catheter-based valve implantation has become a tremendously important development in the treatment of valve disease and the transapical approach allows for treatment of patients with peripheral vascular disease. The group in Vancouver has the largest experience in the world with this modality.
Dr. Lichtenstein holds multiple patents. In 1998, he developed a suture-based mechanical coronary anastomosis system for Perclose. The patented methodology has been adapted for femoral artery closures after interventional cardiological procedures. In 1999, Dr. Lichtenstein co-founded Ventrica, a biotech start-up in Menlo Park, California, based on a magnetic coupling system for coronary anastomosis. More recently, he co-founded biotech start-ups in Vancouver focused on percutaneous solutions for treating atrial fibrillation, methods of reducing x-ray radiation exposure for long fluoroscopic procedures, and non-invasive lung volume reduction for the treatment of emphysema.
Saturday, October 26
2:00 PM – 3:00 PM